ResultsIQ

ResultsIQ › Latest results › Mastek Limited

Mastek Limited Q4 FY25 results deck summary

NSE: MASTEK · BSE: 523704

Results deck of 18 Apr 2025, summarised by AI from the filing.

Q4FY25 revenue ₹905.4 cr, up 16.1% Y-o-Y, with 12-month order backlog at ₹2,290.9 cr and proposed final dividend of ₹16 per share.

Key takeaways

  1. Order backlog 12-month order backlog ₹2,290.9 cr ($264.5 mn) as on 31 March 2025, up 7.1% Q-o-Q and 5.6% Y-o-Y in rupee terms.
  2. Margin change Operating EBITDA margin fell to 15.3% in Q4FY25 from 16.2% in Q3FY25, down 85 bps Q-o-Q.
  3. Growth driver Healthcare vertical grew 13.1% Q-o-Q in USD terms; UK healthcare and secured government services show momentum.
  4. Main risk Macroeconomic uncertainties persist, though management cites execution focus and client partnerships for sustainable growth.

Original filing on BSE

Mastek Limited Q1 FY27 results

As filed: Revenue ₹985 cr (+8% year on year), EBITDA ₹151 cr (+10% year on year), PAT ₹106 cr (+15% year on year), EBITDA margin 15.4% (+39 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹938 cr (+4% year on year), EBITDA ₹151 cr (+8% year on year), PAT ₹106 cr (+31% year on year), EBITDA margin 16.1% (+71 bps). Score 55 of 100, In line with trend. Revenue growth was well below the company's own trend; EBITDA growth was above it; profit before exceptional items growth was well above it. EBITDA margin rose 71 bps year on year. Share price after the results: −11.2% in 28 days (Nifty 500: −1.5%).
  • Q3 FY26: Revenue ₹906 cr (+4% year on year), EBITDA ₹146 cr (+3% year on year), PAT ₹108 cr (+14% year on year), EBITDA margin 16.1% (−25 bps). Score 38 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was below it; profit growth was in line with it. EBITDA margin fell 25 bps year on year. Revenue fell 4% from last quarter. Revenue rose ₹35.7 cr on a year ago, against ₹86.0 cr the year before. Share price after the results: −22.0% in 30 days (Nifty 500: +2.0%).
  • Q2 FY26: Revenue ₹940 cr (+8% year on year), EBITDA ₹146 cr (+2% year on year), PAT ₹97.0 cr (−25% year on year), EBITDA margin 15.5% (−96 bps). Score 27 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend; profit growth was well below it. EBITDA margin fell 96 bps year on year. Consolidated profit -25% but standalone +17%. Revenue rose ₹73.0 cr on a year ago, against ₹101 cr the year before. Share price after the results: +5.0% in 29 days (Nifty 500: +2.0%).
  • Q1 FY26: Revenue ₹915 cr (+13% year on year), EBITDA ₹137 cr (+10% year on year), PAT ₹92.0 cr (+28% year on year), EBITDA margin 15.0% (−28 bps). Score 57 of 100, In line with trend. Revenue, EBITDA and profit growth were in line with the company's own trend. EBITDA margin fell 28 bps year on year. Revenue rose ₹102 cr on a year ago, more than the ₹88.0 cr it added the year before. Share price after the results: −2.0% in 28 days (Nifty 500: −4.4%).
  • Q4 FY25: Revenue ₹905 cr (+16% year on year), EBITDA ₹139 cr (+11% year on year), PAT ₹81.0 cr (−14% year on year), EBITDA margin 15.4% (−67 bps). Score 53 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend; profit growth was well below it. EBITDA margin fell 67 bps year on year. Consolidated profit -14% but standalone +19%. Profit fell 15% from last quarter. Revenue rose ₹125 cr on a year ago, more than the ₹71.0 cr it added the year before. Share price after the results: +0.6% in 28 days (Nifty 500: +5.5%).
  • Q3 FY25: Revenue ₹870 cr (+11% year on year), EBITDA ₹142 cr (+6% year on year), PAT ₹95.0 cr (+22% year on year), EBITDA margin 16.3% (−77 bps). Score 46 of 100, In line with trend. Revenue and profit growth were below the company's own trend; EBITDA growth was in line with it. EBITDA margin fell 77 bps year on year. Consolidated profit +22% but standalone -106%. Profit fell 26% from last quarter. Profit rose ₹17.0 cr on a year ago, more than the ₹11.0 cr it added the year before.
  • Q2 FY25: Revenue ₹867 cr (+13% year on year), EBITDA ₹143 cr (+16% year on year), PAT ₹129 cr (+98% year on year), EBITDA margin 16.5% (+44 bps). Score 64 of 100, In line with trend. EBITDA margin rose 44 bps year on year. Tax rate 0%. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Mastek Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.